Advanced search
Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Email Registration
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Veradigm Inc.
  6. Consensus
    MDRX   US01988P1084

VERADIGM INC.

(MDRX)
  Report
Delayed Nasdaq  -  04:00:00 2023-01-27 pm EST
17.75 USD   -1.77%
01/11Transcript : Veradigm Inc. Presents at 41st Annual J.P. Morgan Healthcare Conference, Jan-11-2023 03:45 PM
CI
01/11Veradigm Approves Share Buyback Plan of Up to $250 Million, Provides Fiscal 2023 Guidance
MT
01/11Veradigm Inc. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Evolution of the average Target Price on VERADIGM INC.
Target Price consensus revisions : last 18 months
Recommendations (Chart) VERADIGM INC.
Analyst Recommendations on VERADIGM INC.
2022JPMorgan Adjusts Price Target on Allscripts Healthcare Solutions to $20 From $19, Maintain..
MT
2022Goldman Sachs Upgrades Allscripts Healthcare Solutions to Buy From Neutral, Adjusts Price ..
MT
2022Deutsche Bank Adjusts Allscripts Healthcare Solutions Price Target to $21 From $20, Mainta..
MT
2022Deutsche Bank Adjusts Price Target on Allscripts Healthcare Solutions to $20 From $26, Mai..
MT
2022KeyBanc Initiates Coverage on Allscripts Healthcare Solutions With Sector Weight Rating
MT
2022Goldman Sachs Starts Allscripts Healthcare Solutions at Neutral With $21 Price Target
MT
2022Piper Sandler Adjusts Price Target on Allscripts Healthcare Solutions to $17 From $19, Mai..
MT
More recommendations
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 9
Last Close Price 17,75 $
Average target price 21,86 $
Spread / Average Target 23,1%
High Price Target 26,00 $
Spread / Highest target 46,5%
Low Price Target 17,00 $
Spread / Lowest Target -4,23%
Consensus detail
Consensus revision (last 18 months)